The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

CXPTA     2-[4-chloro-6-[(2,3- dimethylphenyl)amino]p...

Synonyms: Pirinixic acid, Tocris-1312, Pirnixic acid, CCRIS 133, Wyeth-14643, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Pirinixic acid


High impact information on Pirinixic acid


Chemical compound and disease context of Pirinixic acid


Biological context of Pirinixic acid


Anatomical context of Pirinixic acid


Associations of Pirinixic acid with other chemical compounds


Gene context of Pirinixic acid


Analytical, diagnostic and therapeutic context of Pirinixic acid


  1. Differences between the promoting activities of the peroxisome proliferator WY-14,643 and phenobarbital in rat liver. Cattley, R.C., Popp, J.A. Cancer Res. (1989) [Pubmed]
  2. Antagonism of the actions of peroxisome proliferator-activated receptor-alpha by bile acids. Sinal, C.J., Yoon, M., Gonzalez, F.J. J. Biol. Chem. (2001) [Pubmed]
  3. Hypoxia-inducible factor 1-mediated inhibition of peroxisome proliferator-activated receptor alpha expression during hypoxia. Narravula, S., Colgan, S.P. J. Immunol. (2001) [Pubmed]
  4. Interactive influences of peroxisome proliferator-activated receptor alpha activation and glucocorticoids on pancreatic beta cell compensation in insulin resistance induced by dietary saturated fat in the rat. Holness, M.J., Smith, N.D., Greenwood, G.K., Sugden, M.C. Diabetologia (2005) [Pubmed]
  5. Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643. Collino, M., Aragno, M., Mastrocola, R., Benetti, E., Gallicchio, M., Dianzani, C., Danni, O., Thiemermann, C., Fantozzi, R. Free Radic. Biol. Med. (2006) [Pubmed]
  6. Mechanism of action of the nongenotoxic peroxisome proliferators: role of the peroxisome proliferator-activator receptor alpha. Gonzalez, F.J., Peters, J.M., Cattley, R.C. J. Natl. Cancer Inst. (1998) [Pubmed]
  7. PPARalpha agonists inhibit tissue factor expression in human monocytes and macrophages. Neve, B.P., Corseaux, D., Chinetti, G., Zawadzki, C., Fruchart, J.C., Duriez, P., Staels, B., Jude, B. Circulation (2001) [Pubmed]
  8. PPARalpha activators inhibit tissue factor expression and activity in human monocytes. Marx, N., Mackman, N., Schönbeck, U., Yilmaz, N., Hombach, V., Libby, P., Plutzky, J. Circulation (2001) [Pubmed]
  9. Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Göttlicher, M., Widmark, E., Li, Q., Gustafsson, J.A. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  10. Expression of base excision DNA repair genes is a sensitive biomarker for in vivo detection of chemical-induced chronic oxidative stress: identification of the molecular source of radicals responsible for DNA damage by peroxisome proliferators. Rusyn, I., Asakura, S., Pachkowski, B., Bradford, B.U., Denissenko, M.F., Peters, J.M., Holland, S.M., Reddy, J.K., Cunningham, M.L., Swenberg, J.A. Cancer Res. (2004) [Pubmed]
  11. Etomoxir-induced PPARalpha-modulated enzymes protect during acute renal failure. Portilla, D., Dai, G., Peters, J.M., Gonzalez, F.J., Crew, M.D., Proia, A.D. Am. J. Physiol. Renal Physiol. (2000) [Pubmed]
  12. Dietary glycine inhibits the growth of B16 melanoma tumors in mice. Rose, M.L., Madren, J., Bunzendahl, H., Thurman, R.G. Carcinogenesis (1999) [Pubmed]
  13. Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2. K??nig, B., Koch, A., Spielmann, J., Hilgenfeld, C., Stangl, G.I., Eder, K. Biochem. Pharmacol. (2007) [Pubmed]
  14. PPARalpha agonists up-regulate organic cation transporters in rat liver cells. Luci, S., Geissler, S., K??nig, B., Koch, A., Stangl, G.I., Hirche, F., Eder, K. Biochem. Biophys. Res. Commun. (2006) [Pubmed]
  15. The genetic toxicity of the peroxisome proliferator class of rodent hepatocarcinogen. Galloway, S.M., Johnson, T.E., Armstrong, M.J., Ashby, J. Mutat. Res. (2000) [Pubmed]
  16. Peroxisome proliferators activate Kupffer cells in vivo. Bojes, H.K., Thurman, R.G. Cancer Res. (1996) [Pubmed]
  17. Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Brun, S., Carmona, M.C., Mampel, T., Viñas, O., Giralt, M., Iglesias, R., Villarroya, F. Diabetes (1999) [Pubmed]
  18. Peroxisome proliferator-activated receptor alpha inhibits hepatic S14 gene transcription. Evidence against the peroxisome proliferator-activated receptor alpha as the mediator of polyunsaturated fatty acid regulation of s14 gene transcription. Ren, B., Thelen, A., Jump, D.B. J. Biol. Chem. (1996) [Pubmed]
  19. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E. Lee, M.J., Gee, P., Beard, S.E. Cancer Res. (1997) [Pubmed]
  20. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate. Peters, J.M., Zhou, Y.C., Ram, P.A., Lee, S.S., Gonzalez, F.J., Waxman, D.J. Mol. Pharmacol. (1996) [Pubmed]
  21. Thiazolidinediones downregulate stearoyl-CoA desaturase 1 gene expression in 3T3-L1 adipocytes. Kurebayashi, S., Hirose, T., Miyashita, Y., Kasayama, S., Kishimoto, T. Diabetes (1997) [Pubmed]
  22. Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene. Pedraza, N., Solanes, G., Carmona, M.C., Iglesias, R., Viñas, O., Mampel, T., Vazquez, M., Giralt, M., Villarroya, F. Diabetes (2000) [Pubmed]
  23. Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. Jung, D., Fried, M., Kullak-Ublick, G.A. J. Biol. Chem. (2002) [Pubmed]
  24. Peroxisome proliferator-activated receptor (PPAR)-alpha activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-gamma activation. Ye, J.M., Doyle, P.J., Iglesias, M.A., Watson, D.G., Cooney, G.J., Kraegen, E.W. Diabetes (2001) [Pubmed]
  25. Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. Lindén, D., Lindberg, K., Oscarsson, J., Claesson, C., Asp, L., Li, L., Gustafsson, M., Borén, J., Olofsson, S.O. J. Biol. Chem. (2002) [Pubmed]
  26. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Kliewer, S.A., Forman, B.M., Blumberg, B., Ong, E.S., Borgmeyer, U., Mangelsdorf, D.J., Umesono, K., Evans, R.M. Proc. Natl. Acad. Sci. U.S.A. (1994) [Pubmed]
  27. Effect of PPAR activators on cytokine-stimulated cyclooxygenase-2 expression in human colorectal carcinoma cells. Ikawa, H., Kameda, H., Kamitani, H., Baek, S.J., Nixon, J.B., Hsi, L.C., Eling, T.E. Exp. Cell Res. (2001) [Pubmed]
  28. Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Combs, C.K., Bates, P., Karlo, J.C., Landreth, G.E. Neurochem. Int. (2001) [Pubmed]
  29. 15-Deoxy-Delta(12,14)-prostaglandin J2 inhibits the expression of proinflammatory genes in human blood monocytes via a PPAR-gamma-independent mechanism. Hinz, B., Brune, K., Pahl, A. Biochem. Biophys. Res. Commun. (2003) [Pubmed]
  30. Sustained formation of alpha-(4-pyridyl-1-oxide)-N-tert-butylnitrone radical adducts in mouse liver by peroxisome proliferators is dependent upon peroxisome proliferator-activated receptor-alpha, but not NADPH oxidase. Woods, C.G., Burns, A.M., Maki, A., Bradford, B.U., Cunningham, M.L., Connor, H.D., Kadiiska, M.B., Mason, R.P., Peters, J.M., Rusyn, I. Free Radic. Biol. Med. (2007) [Pubmed]
  31. Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectable foci in rat liver. Cattley, R.C., Marsman, D.S., Popp, J.A. Toxicology (1989) [Pubmed]
  32. Hepatic expression of polymerase beta, Ref-1, PCNA, and Bax in WY 14,643-exposed rats and hamsters. Holmes, E.W., Bingham, C.M., Cunningham, M.L. Exp. Mol. Pathol. (2002) [Pubmed]
  33. Peroxisome proliferator-activated receptor a ligands increase lectin-like oxidized low density lipoprotein receptor-1 expression in vascular endothelial cells. Hayashida, K., Kume, N., Minami, M., Kataoka, H., Morimoto, M., Kita, T. Ann. N. Y. Acad. Sci. (2001) [Pubmed]
WikiGenes - Universities